As our data indicate, TAMs likely secrete CCL20, and CCR6-expressed RCC cells consume CCL20 in the tumor microenvironment of RCC, resulting in an increased migration ability of the RCC cells. The gene discussed is CCR6; the disease is renal cell carcinoma.